Blood co-expression modules identify potential modifier genes of diabetes and lung function in cystic fibrosis.
Cystic fibrosis (CF) is a rare genetic disease that affects the respiratory and digestive systems. Lung disease is variable among CF patients and associated with the development of comorbidities and chronic infections. The rate of lung function deterioration depends not only on the type of mutations...
Main Authors: | Fanny Pineau, Davide Caimmi, Milena Magalhães, Enora Fremy, Abdillah Mohamed, Laurent Mely, Sylvie Leroy, Marlène Murris, Mireille Claustres, Raphael Chiron, Albertina De Sario |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0231285 |
Similar Items
-
DNA Methylation at <i>ATP11A</i> cg11702988 Is a Biomarker of Lung Disease Severity in Cystic Fibrosis: A Longitudinal Study
by: Fanny Pineau, et al.
Published: (2021-03-01) -
Comprehensive allergy work-up is mandatory in cystic fibrosis patients who report a history suggestive of drug allergy to beta-lactam antibiotics
by: Caimmi Silvia, et al.
Published: (2012-06-01) -
Management of initial colonisations with Burkholderia species in France, with retrospective analysis in five cystic fibrosis Centres: a pilot study
by: Vianney Gruzelle, et al.
Published: (2020-06-01) -
A Powerful and Universal Preimplantation Genetic Diagnosis Protocol for Cystic Fibrosis
by: Victoria Viart, et al.
Published: (2018-08-01) -
Are p.I148T, p.R74W and p.D1270N cystic fibrosis causing mutations ?
by: Chevalier-Porst Françoise, et al.
Published: (2004-08-01)